Literature DB >> 28747800

Regenerative medicine: Breaking Prometheus's curse for cartilage regeneration.

Florence Apparailly1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28747800     DOI： 10.1038/nrrheum.2017.116

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation.

Authors:  Hélène Le Buanec; Laure Delavallée; Natacha Bessis; Sébastien Paturance; Bernard Bizzini; Robert Gallo; Daniel Zagury; Marie-Christophe Boissier
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-08       Impact factor: 11.205

Review 2.  Treatment of rheumatoid arthritis: state of the art 2009.

Authors:  Ronald F van Vollenhoven
Journal:  Nat Rev Rheumatol       Date:  2009-10       Impact factor: 20.543

Review 3.  Management of juvenile idiopathic arthritis: hitting the target.

Authors:  Claas Hinze; Faekah Gohar; Dirk Foell
Journal:  Nat Rev Rheumatol       Date:  2015-01-06       Impact factor: 20.543

Review 4.  Gene therapy for rheumatoid arthritis: current status and future prospects.

Authors:  Sylvie Fabre; Florence Apparailly
Journal:  BioDrugs       Date:  2011-12-01       Impact factor: 5.807

5.  Intra-articular etanercept treatment in inflammatory arthritis: A randomized double-blind placebo-controlled proof of mechanism clinical trial validating TNF as a potential therapeutic target for local treatment.

Authors:  Caroline Aalbers; Danielle Gerlag; Koen Vos; Margriet Vervoordeldonk; Robert Landewé; Paul Peter Tak
Journal:  Joint Bone Spine       Date:  2015-07-15       Impact factor: 4.929

Review 6.  siRNA-based therapeutic approaches for rheumatic diseases.

Authors:  Florence Apparailly; Christian Jorgensen
Journal:  Nat Rev Rheumatol       Date:  2012-10-23       Impact factor: 20.543

7.  Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial.

Authors:  Yves-Marie Pers; Lars Rackwitz; Rosanna Ferreira; Oliver Pullig; Christophe Delfour; Frank Barry; Luc Sensebe; Louis Casteilla; Sandrine Fleury; Philippe Bourin; Danièle Noël; François Canovas; Catherine Cyteval; Gina Lisignoli; Joachim Schrauth; Daniel Haddad; Sophie Domergue; Ulrich Noeth; Christian Jorgensen
Journal:  Stem Cells Transl Med       Date:  2016-05-23       Impact factor: 6.940

8.  Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-β (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis.

Authors:  Caroline J Aalbers; Lisette Bevaart; Scott Loiler; Karin de Cortie; J Fraser Wright; Federico Mingozzi; Paul P Tak; Margriet J Vervoordeldonk
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

9.  Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs.

Authors:  Jonathan M Brunger; Ananya Zutshi; Vincent P Willard; Charles A Gersbach; Farshid Guilak
Journal:  Stem Cell Reports       Date:  2017-04-27       Impact factor: 7.765

Review 10.  Gene therapy for arthritis.

Authors:  Russell S Traister; Raphael Hirsch
Journal:  Mod Rheumatol       Date:  2008-01-05       Impact factor: 3.023
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.